首页> 外文期刊>Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology >Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
【24h】

Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.

机译:口服避孕药组合对功能性卵巢储备的定量作用(通过血清抗苗勒氏激素和三维超声检测小卵泡计数)。

获取原文
获取原文并翻译 | 示例
           

摘要

Oral contraceptive pills suppress the hypothalomo-pituitary axis, which can affect the ultrasound and endocrine markers used to examine ovarian reserve. The objective of this study was to quantify the ultrasound and endocrine markers of functional ovarian reserve in women using a combined oral contraceptive pill (COCP) for more than a year.This was a prospective case-control study involving healthy volunteers: 34 women using for more than a year a COCP with hormone-free interval (HFI) were compared to 36 normo-ovulatory, age-matched controls who had not used hormonal contraception within the last year. Volunteers using a COCP underwent a 3D ultrasound examination and had a blood sample taken within the first 4 days of active pill ingestion and those in the control group had the scan and blood test in the early follicular phase (days 2-5) of menstrual cycle. The main outcome measure was the difference in antral follicle counts stratified according to size and anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) levels.There were no significant differences in the number of small antral follicles measuring 2-6 mm. The COCP group had significantly fewer antral follicles measuring ≥ 6 mm (P < 0.001) and had significantly smaller ovaries (P < 0.001), which also had lower vascular indices than the control group (P < 0.05). While serum FSH, LH and E2 levels were significantly lower in the COCP group (P < 0.05), there was no significant difference in serum AMH levels between the two groups.Prolonged use of COCP suppressed pituitary gonadotropins and antral follicle development beyond 6 mm, but had no effect on levels of serum AMH and number of small antral follicles. Copyright ? 2012 ISUOG. Published by John Wiley & Sons, Ltd.
机译:口服避孕药会抑制下丘脑-垂体轴,这可能会影响用于检查卵巢储备的超声和内分泌标记物。这项研究的目的是使用联合口服避孕药(COCP)超过一年的女性来量化女性功能性卵巢储备的超声和内分泌标志物,这是一项涉及健康志愿者的前瞻性病例对照研究:34名女性将超过一年的无激素间隔COCP与36名在过去一年内未使用激素避孕的正常排卵,年龄匹配的对照组进行比较。使用COCP的志愿者接受了3D超声检查,并在主动服药的头4天内采集了血样,对照组的患者在月经周期的早期卵泡期(第2-5天)进行了扫描和血液检查。主要结局指标是根据大小和抗苗勒管激素(AMH),促卵泡激素(FSH),促黄体激素(LH)和雌二醇(E2)水平分层的卵泡计数差异。大小为2-6毫米的小肛门卵泡的数量。 COCP组的≥6 mm的窦卵泡明显较少(P <0.001),卵巢明显较小(P <0.001),血管指数也低于对照组(P <0.05)。虽然COCP组的血清FSH,LH和E2水平明显降低(P <0.05),但两组之间的AMH水平无显着差异。长时间使用COCP抑制垂体促性腺激素和卵泡发育超过6 mm,但对血清AMH的水平和小窦卵泡的数量没有影响。版权? 2012年ISUOG。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号